APA (7th ed.) Citation

Haferlach, C., Bacher, U., Haferlach, T., Dicker, F., Alpermann, T., Kern, W., & Schnittger, S. (2011). The inv(3)(q21q26)/t(3;3)(q21;q26) is frequently accompanied by alterations of the RUNX1, KRAS and NRAS and NF1 genes and mediates adverse prognosis both in MDS and in AML: A study in 39 cases of MDS or AML. Leukemia (08876924), 25(5), 874. https://doi.org/10.1038/leu.2011.5

Chicago Style (17th ed.) Citation

Haferlach, C., U. Bacher, T. Haferlach, F. Dicker, T. Alpermann, W. Kern, and S. Schnittger. "The Inv(3)(q21q26)/t(3;3)(q21;q26) Is Frequently Accompanied by Alterations of the RUNX1, KRAS and NRAS and NF1 Genes and Mediates Adverse Prognosis Both in MDS and in AML: A Study in 39 Cases of MDS or AML." Leukemia (08876924) 25, no. 5 (2011): 874. https://doi.org/10.1038/leu.2011.5.

MLA (9th ed.) Citation

Haferlach, C., et al. "The Inv(3)(q21q26)/t(3;3)(q21;q26) Is Frequently Accompanied by Alterations of the RUNX1, KRAS and NRAS and NF1 Genes and Mediates Adverse Prognosis Both in MDS and in AML: A Study in 39 Cases of MDS or AML." Leukemia (08876924), vol. 25, no. 5, 2011, p. 874, https://doi.org/10.1038/leu.2011.5.